• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    53 Stocks Moving In Thursday's Mid-Day Session

    6/2/22 12:17:59 PM ET
    $ACOR
    $AGLE
    $AHI
    $AI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACOR alert in real time by email

    Gainers

    • Repare Therapeutics Inc. (NASDAQ:RPTX) jumped 38.1% to $12.08 after the company announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib. Repare will receive a $125 million upfront payment and is eligible to receive up to an additional $1.2 billion in potential milestones.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) rose 28.1% to $7.18 after declining over 16% on Wednesday.
    • Yumanity Therapeutics, Inc. (NASDAQ:YMTX) gained 25.3% to $1.4288. Yumanity Therapeutics, last month, posted a Q1 loss of $1.24 per share.
    • Avaya Holdings Corp. (NYSE:AVYA) jumped 24.4% to $5.30.
    • MDJM Ltd (NASDAQ:MDJH) gained 24.2% to $2.0494.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) rose 24.1% to $2.2950 after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
    • American Superconductor Corporation (NASDAQ:AMSC) gained 23.8% to $6.54 following Q4 results.
    • Missfresh Limited (NASDAQ:MF) rose 21.6% to $0.2978 after gaining over 51% on Wednesday.
    • electroCore, Inc. (NASDAQ:ECOR) gained 20.4% to $0.6204.
    • Credo Technology Group Holding Ltd (NASDAQ:CRDO) gained 20% to $12.30 after the company reported Q4 EPS results up from last year and better-than-expected sales results. The company also issued Q1 sales guidance above analyst estimates.
    • PyroGenesis Canada Inc. (NASDAQ:PYR) jumped 18.8% to $3.04. PyroGenesis announced project to introduce plasma torches into the upstream anode baking process.
    • Pure Storage, Inc. (NYSE:PSTG) shares climbed 18.6% to $28.48 after the company reported better-than-expected Q1 financials results. The company also issued Q2 and FY23 sales guidance above analyst estimates.
    • Chewy, Inc. (NYSE:CHWY) rose 18.5% to $27.85 after the company reported better-than-expected Q1 sales results.
    • Uranium Energy Corp. (NYSE:UEC) gained 17.6% to $4.1750.
    • MongoDB, Inc. (NASDAQ:MDB) rose 17.4% to $284.11 after the company reported Q1 EPS results up from last year and better-than-expected sales results. The company also issued Q2 sales guidance above analysts’ estimates.
    • Rain Therapeutics Inc. (NASDAQ:RAIN) jumped 17.2% to $2.86. Roth Capital initiated coverage on Rain Therapeutics with a Buy rating and announced a price target of $16.
    • Dunxin Financial Holdings Limited (NYSE:DXF) rose 17.2% to $0.58.
    • RISE Education Cayman Ltd (NASDAQ:REDU) gained 17.1% to $1.64.
    • Integrated Media Technology Limited (NASDAQ:IMTE) jumped 17% to $9.39.
    • UiPath Inc. (NYSE:PATH) shares rose 16.1% to $19.54 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q3 and FY23 sales guidance above analysts’ estimates.
    • Gevo, Inc. (NASDAQ:GEVO) gained 15.8% to $4.7401. Gevo, last month, reported better-than-expected Q1 sales results.
    • MicroVision, Inc. (NASDAQ:MVIS) jumped 15.6% to $3.9650.
    • Elastic N.V. (NYSE:ESTC) rose 15.4% to $71.50 after the company reported better-than-expected Q4 EPS and sales results.
    • KE Holdings Inc. (NYSE:BEKE) gained 15.1% to $14.58. KE Holdings recently announced better-than-expected Q1 sales results.
    • Onconova Therapeutics, Inc. (NASDAQ:ONTX) surged 14.9% to $1.3101.
    • Lands' End, Inc. (NASDAQ:LE) jumped 14.7% to $12.78 after the company reported better-than-expected Q1 EPS results.
    • Pineapple Energy Inc. (NASDAQ:PEGY) jumped 14.4% to $2.39.
    • Veeva Systems Inc. (NYSE:VEEV) surged 14% to $191.36 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 and FY22 EPS guidance above analysts estimates.
    • comScore, Inc. (NASDAQ:SCOR) gained 13.9% to $2.21. comScore Director Paul William Livek acquired a total of 600,000 shares at an average price of $1.92.
    • Bright Green Corporation (NASDAQ:BGXX) gained 13.3% to $4.0101 after dropping 30% on Wednesday.
    • Blue Apron Holdings, Inc. (NYSE:APRN) rose 9.7% to $3.3663 after the company announced it will be offering a selection of meal kits without a subscription on Walmart.com.


    Losers

    • Zosano Pharma Corporation (NASDAQ:ZSAN) fell 47.4% to $0.9250 after the company announced it filed a voluntary petition for relief under chapter 11.
    • Immunic, Inc. (NASDAQ:IMUX) shares dipped 41.2% to $3.47 after the company reported data from its Phase 2 CALDOSE-1 trial of Vidofludimus Calcium did not achieve the primary endpoint.
    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) dropped 40.1% to $0.8983. Aeglea BioTherapeutics announced the U.S. Food and Drug Administration (FDA) has refused to accept the company’s Biologics License Application (BLA) with a Refusal to File (RTF) letter.
    • Centessa Pharmaceuticals plc (NASDAQ:CNTA) fell 20% to $3.60 after the company announced it has made a strategic decision to discontinue development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease including both the Phase 3 ACTION study and the open-label ALERT study.
    • WiSA Technologies, Inc. (NASDAQ:WISA) declined 19.4% to $0.6456.
    • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) fell 17% to $3.3740 following effect of 1:10 reverse stock split.
    • CN Energy Group. Inc. (NASDAQ:CNEY) dropped 15.6% to $1.73.
    • Innovid Corp. (NYSE:CTV) fell 15.4% to $2.9950.
    • Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) shares declined 14.9% to $4.56 after the company priced its common stock offering of 10 million shares at $4.75 per share.
    • Midatech Pharma plc (NASDAQ:MTP) dropped 14.7% to $0.64. The U.S. Food and Drug Administration (FDA) recently granted Fast Track Designation to Midatech Pharma PLC's (NASDAQ:MTP) lead drug candidate MTX110 for the treatment of patients with recurrent glioblastoma (rGBM).
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 14.6% to $0.38.
    • Limelight Networks, Inc. (NASDAQ:LLNW) declined 13.9% to $2.9950.
    • Energy Focus, Inc. (NASDAQ:EFOI) fell 13.5% to $1.0550 after jumping 37% on Wednesday.
    • Lightwave Logic, Inc. (NASDAQ:LWLG) dropped 12.4% to $6.95.
    • Mullen Automotive, Inc. (NASDAQ:MULN) fell 11.5% to $1.2550. Mullen Automotive recently announced results of its solid-state polymer battery testing with the Battery Innovation Center in Indiana.
    • Advanced Human Imaging Limited (NASDAQ:AHI) dropped 11.1% to $0.7225.
    • Histogen Inc. (NASDAQ:HSTO) shares fell 10.7% to $0.14. Histogen reported a 1-for-20 reverse stock split.
    • Nutex Health, Inc. (NASDAQ:NUTX) fell 10.5% to $9.64.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) dropped 10.2% to $0.2563.
    • C3.ai, Inc. (NYSE:AI) shares fell 9.8% to $16.73 after the company issued Q1 and FY23 sales guidance below analyst estimates.
    • Conn's, Inc. (NASDAQ:CONN) dropped 9.2% to $11.38. The company reported mixed results for its first quarter.
    • Hewlett Packard Enterprise Company (NYSE:HPE) fell 6.6% to $14.75 after the company reported worse-than-expected Q2 financials results. The company also issued Q3 and FY22 EPS guidance with midpoints below analyst estimates.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $AGLE
    $AHI
    $AI

    CompanyDatePrice TargetRatingAnalyst
    Elastic N.V.
    $ESTC
    4/23/2026$49.00Neutral
    Rothschild & Co Redburn
    Elastic N.V.
    $ESTC
    4/21/2026$50.00Neutral
    Goldman
    Immunic Inc.
    $IMUX
    4/17/2026$2.50Buy
    Stifel
    Immunic Inc.
    $IMUX
    4/15/2026Buy → Hold
    D. Boral Capital
    Credo Technology Group Holding Ltd
    $CRDO
    4/13/2026$175.00Buy
    Jefferies
    Hewlett Packard Enterprise Company
    $HPE
    4/13/2026$29.00Strong Buy → Outperform
    Raymond James
    Centessa Pharmaceuticals plc
    $CNTA
    4/13/2026$38.00Buy → Hold
    Truist
    Veeva Systems Inc.
    $VEEV
    4/10/2026$176.00Buy → Neutral
    Citigroup
    More analyst ratings

    $ACOR
    $AGLE
    $AHI
    $AI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACOR
    $AGLE
    $AHI
    $AI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KE Holdings Inc. Releases 2025 Environmental, Social and Governance Report

    BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. ("Beike" or the "Company") (NYSE:BEKE, HKEX: 2423)), a leading integrated online and offline platform for housing transactions and services, today released its 2025 Environmental, Social and Governance report (the "2025 ESG Report"), highlighting Beike's ongoing efforts to strengthen its governance framework, enhance residential service experiences, empower industry participants through technology, and contribute to a sustainable future for the value chain, all underpinned by its mission of "Admirable service, joyful living." Mr. Stanley Yongdong Peng, Co-founder, Chairman of the Board, and Chief Executive Officer of Beike, comm

    4/24/26 7:14:03 AM ET
    $BEKE
    Real Estate
    Finance

    KE Holdings Inc. Files Its Annual Report on Form 20-F

    BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. ("Beike" or the "Company") (NYSE:BEKE), a leading integrated online and offline platform for housing transactions and services, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission on April 24, 2026. The annual report can be accessed on the Company's investor relations website at https://investors.ke.com. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company's I

    4/24/26 7:13:43 AM ET
    $BEKE
    Real Estate
    Finance

    KE Holdings Inc. to Hold Annual General Meeting on June 12, 2026

    BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. ("Beike" or the "Company") (NYSE:BEKE), a leading integrated online and offline platform for housing transactions and services, today announced that it will hold an annual general meeting of the Company's shareholders (the "AGM") at 3:00 p.m. Beijing time on Friday, June 12, 2026 at Oriental Electronic Technology Building, No. 2 Chuangye Road, Haidian District, Beijing, PRC, for the purposes of considering and, if thought fit, passing each of the Proposed Resolutions as defined and set forth in the notice of the AGM (the "AGM Notice"). A circular of the Company dated April 24, 2026 in relation to the AGM, the AGM Notice and the f

    4/24/26 6:27:08 AM ET
    $BEKE
    Real Estate
    Finance

    $ACOR
    $AGLE
    $AHI
    $AI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Elastic with a new price target

    Rothschild & Co Redburn initiated coverage of Elastic with a rating of Neutral and set a new price target of $49.00

    4/23/26 7:55:51 AM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    Goldman initiated coverage on Elastic with a new price target

    Goldman initiated coverage of Elastic with a rating of Neutral and set a new price target of $50.00

    4/21/26 7:32:58 AM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    Stifel initiated coverage on Immunic with a new price target

    Stifel initiated coverage of Immunic with a rating of Buy and set a new price target of $2.50

    4/17/26 8:12:09 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    SEC Filings

    View All

    SEC Form S-3 filed by MicroVision Inc.

    S-3 - MICROVISION, INC. (0000065770) (Filer)

    4/24/26 5:20:23 PM ET
    $MVIS
    Industrial Machinery/Components
    Technology

    SEC Form 6-K filed by KE Holdings Inc

    6-K - KE Holdings Inc. (0001809587) (Filer)

    4/24/26 7:45:44 AM ET
    $BEKE
    Real Estate
    Finance

    SEC Form 6-K filed by KE Holdings Inc

    6-K - KE Holdings Inc. (0001809587) (Filer)

    4/24/26 7:27:35 AM ET
    $BEKE
    Real Estate
    Finance

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    Chief Executive Officer Huang Chiao Chieh bought $600,001 worth of shares (262,009 units at $2.29), increasing direct ownership by 23% to 1,421,219 units (SEC Form 4)

    4 - ENERGY FOCUS, INC/DE (0000924168) (Issuer)

    12/31/25 9:21:21 AM ET
    $EFOI
    Building Products
    Consumer Discretionary

    CEO and Chairman Rachman Ilya M bought $4,976 worth of shares (746 units at $6.67), increasing direct ownership by 0.07% to 1,141,683 units (SEC Form 4)

    4 - Immix Biopharma, Inc. (0001873835) (Issuer)

    12/10/25 6:49:30 PM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Cheng Chi Fung sold $5,170,522 worth of Ordinary Shares (27,500 units at $188.02) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Credo Technology Group Holding Ltd (0001807794) (Issuer)

    4/24/26 3:06:32 PM ET
    $CRDO
    Semiconductors
    Technology

    SEC Form 4 filed by Director Reed Michael Lee

    4 - Nutex Health Inc. (0001479681) (Issuer)

    4/24/26 2:35:38 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Saunders Scott J

    4 - Nutex Health Inc. (0001479681) (Issuer)

    4/24/26 2:32:08 PM ET
    $NUTX
    Real Estate

    $ACOR
    $AGLE
    $AHI
    $AI
    Leadership Updates

    Live Leadership Updates

    View All

    Gevo Appoints Joan Cetera as Vice President, Communications and Public Relations

    ENGLEWOOD, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels and chemicals and carbon management, today announced the appointment of Joan Cetera as Vice President of Communications and Public Relations, further supporting Gevo's broader leadership transition. Joan brings extensive experience leading enterprise communications for publicly traded companies, with expertise spanning executive communications, reputational management and communications strategy during periods of organizational change. Over her more than 20-year career, she has partnered closely with senior leadership teams to align external perception with business strategy and stak

    4/13/26 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Flow Sciences Appoints Michael Gesser as Chief Financial Officer

    Life Sciences Finance Veteran and Flow Sciences Board Member Steps Into CFO Role to Support Company's Next Phase of GrowthRALEIGH, N.C, April 8, 2026 /PRNewswire/ -- Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Michael Gesser as its chief financial officer. Gesser, who has served as a member of the Flow Sciences board of directors since 2021, will continue serving on the board while assuming executive responsibility for all finance, accounting, tax, treasury, FP&A and investor relations functions.

    4/8/26 8:00:00 AM ET
    $ACOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Gevo Appoints Key Executive Team Members

    ENGLEWOOD, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels, chemicals, and carbon management, today announced the appointments of Kyle James as Chief Commercial Officer and Dave Kettner as General Counsel, further supporting Gevo's broader leadership transition. The executive additions round out newly appointed Chief Executive Officer Paul Bloom's executive team, increasing expertise across renewable fuels, chemicals and value-driven commercial strategies and expanding the company's legal expertise and first-hand experience scaling renewable fuels and technology businesses. "I am excited to welcome Kyle and Dave to Gevo. Kyle's deep experien

    4/1/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stock Movement: Insider Purchase at electroCore Inc. on Jun 6

    **Analysis of Recent Insider Purchase at electroCore Inc.** An insider purchase was recently made at electroCore Inc. by Goldberger Daniel S on June 6, 2024. This transaction involved the purchase of $247,587 worth of shares, equating to 38,505 units at an average price of $6.43 per share. As a result of this purchase, Goldberger's direct ownership in the company increased by 18% to 249,565 units, as reported in the SEC Form 4 filing. Looking at the historical insider transactions at electroCore Inc., several interesting patterns emerge when analyzing the timing, price, volume, purchaser's role, and more. On August 8, 2023, Goldstein Julie Ann and Cuneo F Peter both filed SEC Form 4 report

    6/10/24 12:57:57 AM ET
    $ECOR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Financials

    Live finance-specific insights

    View All

    Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

    HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the first fiscal quarter ended March 31, 2026, on Thursday, April 30, 2026 after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a b

    4/22/26 4:15:00 PM ET
    $NUTX
    Real Estate

    Gevo to Report First Quarter 2026 Financial Results on May 7, 2026

    ENGLEWOOD, Colo., April 21, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) today announced it will host a conference call at 4:30 p.m. ET (2:30 p.m. MT) Thursday, May 7 to report its financial results for the first quarter that ended March 31. To participate in the live call, please call (800) 715-9871 (U.S. toll-free) or (646) 307-1963 (international). Please reference passcode 3527252 to join the call. To listen to the conference call (audio only, non-participating), please register through the following event weblink: https://edge.media-server.com/mmc/p/mngys3a9   A webcast replay will be available after the conference call ends on May 7. The archived webcast will be available in

    4/21/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 21, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on April 21stThe major averages are climbing Tuesday morning as investors react to the latest developments in Iran and fresh earnings.UiPath (NYSE:PATH) CMO Michael Atalla will join NYSE Live to discuss his company's five-year anniversary as a listed company.HSBC (NYSE:HSBC) Innovation Banking Managing Director Jonathan Norris

    4/21/26 8:55:00 AM ET
    $HSBC
    $ICE
    $PATH
    Savings Institutions
    Finance
    Investment Bankers/Brokers/Service
    Computer Software: Prepackaged Software

    $ACOR
    $AGLE
    $AHI
    $AI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by MongoDB Inc.

    SC 13G/A - MongoDB, Inc. (0001441816) (Subject)

    11/15/24 10:35:42 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Repare Therapeutics Inc.

    SC 13G/A - Repare Therapeutics Inc. (0001808158) (Subject)

    11/14/24 9:00:57 PM ET
    $RPTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centessa Pharmaceuticals plc

    SC 13G/A - Centessa Pharmaceuticals plc (0001847903) (Subject)

    11/14/24 5:43:48 PM ET
    $CNTA
    Biotechnology: Pharmaceutical Preparations
    Health Care